基本统计
| CIK | 72170 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Inergetics, Inc.
SEC Filings (Chronological Order)
本页提供了美国证券交易委员会（SEC）备案的完整、按时间顺序排列的列表，不包括我们在其他地方提供的所有权备案。
| February 22, 2016 |
NRTI / Inergetics, Inc. / ISRAELIAN JOHN - SC 13G/A Passive Investment SC 13G/A 1 v432454sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* INERGETICS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 45671Q204 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the |
|
| February 16, 2016 |
NRTI / Inergetics, Inc. / FRENKEL LEONID Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| September 14, 2015 |
EX-10.1 2 v420207ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 MASTER PURCHASE ORDER ASSIGNMENT AGREEMENT Dated as of September 1, 2015 by and between [] (CONTRACTOR) and [] (CONTRACTOR) and INERGETICS, INC. (DISTRIBUTOR) MASTER PURCHASE ORDER ASSIGNMENT AGREEMENT THIS AGREEMENT (this “Agreement”) is dated as of September 1, 2015, by and among (the “”), (“” and together with collectively, the “Contractors” |
|
| September 14, 2015 |
INERGETICS, INC. SENIOR SECURED CONVERTIBLE DEMAND PROMISSORY NOTE EX-10.2 3 v420207ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) |
|
| September 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2015 INERGETICS, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-3338 22-1558317 (State or other Jurisdiction of Incorporation) (Commission File Nu |
|
| September 14, 2015 |
Exhibit 10.4 SUBORDINATION AGREEMENT THIS SUBORDINATION AGREEMENT (this “Agreement”) is made and executed as of the 1st day of September, 2015, by, between and among INERGETICS, INC., a corporation incorporated under the laws of the State of Delaware (the “Borrower”); _ (“_”),_ (“_,” and together with _, collectively, the “_”) and _ (“_,” and together with the _, collectively, the “Senior Lenders” |
|
| September 14, 2015 |
Exhibit 10.3 SECURITY AGREEMENT This SECURITY AGREEMENT, dated as of September 1, 2015 (as amended, restated or modified from time, this ?Security Agreement?), is executed by, between and among by, between and among INERGETICS, INC., a corporation incorporated under the laws of the State of Delaware (the ?Grantor?), and (??), (?,? and together with , collectively, the ?Contractors?) and (?? and to |
|
| August 19, 2015 |
Inergetics FORM 10-Q (Quarterly Report) FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-3338 NOTIFICATION OF LATE FILING CUSIP NUMBER 60038H 10 2 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2015 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transiti |
|
| July 23, 2015 |
Exhibit 10.2 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 23, 2015 |
Exhibit 10.4 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 23, 2015 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of June 16, 2015, by and between INERGETICS, INC., a DELAWARE corporation, with headquarters located at 550 BROAD STREET, SUITE 1212, NEWARK, NJ 07652 (the ?Company?), and , a , with its address at (the ?Buyer?). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement |
|
| July 23, 2015 |
8-K 1 v4159898k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2015 INERGETICS, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-3338 22-1558317 (State or other Jurisdiction of Incorpora |
|
| July 23, 2015 |
Exhibit 10.3 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of July 13, 2015, by and between INERGETICS, INC., a DELAWARE corporation, with headquarters located at 550 BROAD STREET, SUITE 1212, NEWARK, NJ 07652 (the ?Company?), and , a , with its address at (the ?Buyer?). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement |
|
| June 1, 2015 |
Exhibit 1 Joint Filing Agreement This Joint Filing Agreement, entered into and effective as of May 19, 2015, is made by and between 31 Group, LLC, Magna Equities I, LLC, Magna Equities II, LLC, and Joshua Sason (each, a “ Filer ” and, collectively, the “ Filers ”) pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. |
|
| June 1, 2015 |
NRTI / Inergetics, Inc. / 31 Group LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Inergetics, Inc. (Name of Issuer) COMMON STOCK, $0.001 PAR VALUE (Title of Class of Securities) 45671Q204 (CUSIP Number) May 19, 2015 (Date of Event Which Require |
|
| May 20, 2015 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-3338 NOTIFICATION OF LATE FILING CUSIP NUMBER 60038H 10 2 (Check One) : ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2015 ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( |
|
| May 1, 2015 |
Entry into a Material Definitive Agreement SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of report (Date of earliest event reported): April 16, 2015 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Identifica |
|
| April 15, 2015 |
Exhibit 10.13 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT effective as of October 1, 2012 (the ?Agreement?) by and among Millennium Biotechnologies, Inc., a Delaware corporation (?Company?), Inergetics, Inc. a Delaware corporation (?Inergetics?) and James Kras (the ?Executive?). WHEREAS, Executive had significant business experience; and WHEREAS, Company desires to secure the services of the Executi |
|
| April 15, 2015 |
Exhibit 3(i).6 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND LIMITATIONS OF SERIES G CONVERTIBLE PREFERRED STOCK OF INERGETICS, INC. Acting pursuant to Sections 151(a) and (g) of the Delaware General Corporation Law, the undersigned, Michael C. James, the duly elected and acting Chief Executive Officer of Inergetics, Inc. (the ?Company?) hereby certifies that the Board |
|
| April 15, 2015 |
Exhibit ?21? SUBSIDIARIES Millennium Biotechnologies, Inc., a Delaware corporation. |
|
| April 15, 2015 |
Exhibit 4.1 No. NEITHER THESE SECURITIES NOR THE SHARES INTO WHICH THEY MAY BE CONVERTED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE, AND ARE ISSUED IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT (i) PURSUANT TO AN |
|
| April 15, 2015 |
Exhibit 4.6 NUMBER SHARES ING- INERGETICS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SERIES G CONVERTIBLE PREFERRED STOCK THIS CERTIFIES THAT is the record holder of FULLY PAID AND NON-ASSESSABLE SHARES OF SERIES G CONVERTIBLE PREFERRED STOCK, $1.00 PAR VALUE, $50.00 STATED VALUE OF INERGETICS, INC. (the ?Corporation?), transferable on the books of the Corporation in person or by a |
|
| April 15, 2015 |
Exhibit 10.14 Asset Purchase Agreement THIS ASSET PURCHASE AGREEMENT (?Agreement?) is made on January 9, 2013 by and between Whole Products LLC, P.O. Box 333, Highlands, New Jersey 07732, (the ?Whole Products?), and Millennium Biotechnologies, Inc. (?Millennium?) a wholly owned subsidiary of Inergetics, Inc. (?Inergetics?) both Millennium and Inergetics are located at 205 Robin Road, Suite 222, Pa |
|
| April 15, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 INERGETICS, INC. (Exact Name of Registrant |
|
| April 15, 2015 |
Exhibit 4.7 AMENDMENT TO THE SECURED CONVERTIBLE NOTE FROM INERGETICS, INC. TO DUE DECEMBER 31, 2013 IN THE PRINCIPAL AMOUNT OF $ AND RELATED TRANSACTION DOCUMENTS This Amendment, effective December 31, 2013 (the ?Amendment?), by and between Inergetics, Inc., a corporation organized under the laws of the State of Delaware (?Inergetics?) and its wholly-owned subsidiary, Millennium Biotechnologies, |
|
| April 13, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 v4071658k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of report (Date of earliest event reported): March 31, 2015 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-155 |
|
| April 13, 2015 |
Inergetics Reports Preliminary Full Year 2014 Results EX-99.1 2 v407165ex99-1.htm EXHIBIT 99.1 EXHIBIT 99.1 Inergetics Reports Preliminary Full Year 2014 Results NEWARK, N.J., March 31, 2015 /PRNewswire/ - Inergetics, Inc. (OTCBB: NRTI), a world-class developer of nutritional and consumer health products, today announced preliminary unaudited financial results for its fiscal year ended December 31, 2014. Inergetics is providing certain preliminary un |
|
| March 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-3338 NOTIFICATION OF LATE FILING CUSIP NUMBER 60038H 10 2 (Check One) : x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: 12/31/14 ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( ) Tran |
|
| March 17, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of report (Date of earliest event reported): March 9, 2015 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Identificat |
|
| March 17, 2015 |
EX-4.1 2 v404752ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN |
|
| March 17, 2015 |
EX-10.1 3 v404752ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 9, 2015, by and between INERGETICS, INC., a DELAWARE corporation, with headquarters located at 550 BROAD STREET, SUITE 1212, NEWARK, NJ07652 (the “Company”), and 31 GROUP, LLC, a New York corporation, with its address at 5 Hanover Square, New Y |
|
| February 17, 2015 |
NRTI / Inergetics, Inc. / FRENKEL LEONID Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 30, 2015 |
NRTI / Inergetics, Inc. / ISRAELIAN JOHN - SC 13G/A Passive Investment SC 13G/A 1 v400000sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* INERGETICS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 45671Q204 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the |
|
| December 16, 2014 |
NRTI / Inergetics, Inc. / ISRAELIAN JOHN - SC 13G Passive Investment SC 13G 1 v396704sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* INERGETICS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 45671Q204 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the approp |
|
| November 14, 2014 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| October 31, 2014 |
8-K 1 v3928148k.htm 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 27, 2014 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) |
|
| October 31, 2014 |
INERGETICS, INC CONVERTIBLE DEBENTURE Exhibit 4.1 INERGETICS, INC CONVERTIBLE DEBENTURE $165,000.00 October 27, 2014 THIS DEBENTURE HAS NOT BEEN REGISTERED PURSUANT TO THE SECURITIES ACT OF 1933 (THE "ACT") OR ANY STATE SECURITIES LAW AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AS TO THIS DEBENTURE OR AN OPINION OF COUNSEL SATISFACTORY TO THE CO |
|
| October 17, 2014 |
AMENDMENT NO. 1 TO SECURED SUBORDINATD CONVERTIBLE PROMISSORY NOTE DUE JULY 13, 2015 Exhibit 10.1 AMENDMENT NO. 1 TO SECURED SUBORDINATD CONVERTIBLE PROMISSORY NOTE DUE JULY 13, 2015 This Amendment (the “Amendment”) to the Secured Subordinated Convertible Promissory Note dated as of July 14, 2014 is entered into between Inergetics, Inc., a Delaware corporation (the “Company”) and 31 Group, LLC, a New York corporation (the “Holder”). WHEREAS, the Company issued an Secured Subordina |
|
| October 17, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of report (Date of earliest event reported): October 16, 2014 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Identifi |
|
| October 10, 2014 |
NRTI / Inergetics, Inc. RW - - RW Inergetics October 10, 2014 Via EDGAR Submission Jeffrey Riedler Assistant Director Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: Inergetics, Inc. |
|
| September 22, 2014 |
8-K 1 v3897448k.htm 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of report (Date of earliest event reported): September 16, 2014 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558 |
|
| September 11, 2014 |
S-1/A 1 v388739s1a.htm S-1/A AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 11, 2014 REGISTRATION NO. 333-197784 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INERGETICS, INC. (Exact name of registrant as specified in its charter) Delaware 5122 22-1558317 (State or juris |
|
| August 14, 2014 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| August 1, 2014 |
Exhibit 3(i).6 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND LIMITATIONS OF SERIES G CONVERTIBLE PREFERRED STOCK OF INERGETICS, INC. Acting pursuant to Sections 151(a) and (g) of the Delaware General Corporation Law, the undersigned, Michael C. James, the duly elected and acting Chief Executive Officer of Inergetics, Inc. (the “Company”) hereby certifies that the Board |
|
| August 1, 2014 |
Exhibit 10.13 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT effective as of October 1, 2012 (the “Agreement”) by and among Millennium Biotechnologies, Inc., a Delaware corporation (“Company”), Inergetics, Inc. a Delaware corporation (“Inergetics”) and James Kras (the “Executive”). WHEREAS, Executive had significant business experience; and WHEREAS, Company desires to secure the services of the Executi |
|
| August 1, 2014 |
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 1, 2014 REGISTRATION NO. |
|
| August 1, 2014 |
Exhibit “21” SUBSIDIARIES Millennium Biotechnologies, Inc., a Delaware corporation. |
|
| August 1, 2014 |
Exhibit 4.1 No. NEITHER THESE SECURITIES NOR THE SHARES INTO WHICH THEY MAY BE CONVERTED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE, AND ARE ISSUED IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT (i) PURSUANT TO AN |
|
| August 1, 2014 |
Exhibit 10.14 Asset Purchase Agreement THIS ASSET PURCHASE AGREEMENT (“Agreement”) is made on January 9, 2013 by and between Whole Products LLC, P.O. Box 333, Highlands, New Jersey 07732, (the “Whole Products”), and Millennium Biotechnologies, Inc. (“Millennium”) a wholly owned subsidiary of Inergetics, Inc. (“Inergetics”) both Millennium and Inergetics are located at 205 Robin Road, Suite 222, Pa |
|
| August 1, 2014 |
Exhibit 4.6 NUMBER SHARES ING- INERGETICS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SERIES G CONVERTIBLE PREFERRED STOCK THIS CERTIFIES THAT is the record holder of FULLY PAID AND NON-ASSESSABLE SHARES OF SERIES G CONVERTIBLE PREFERRED STOCK, $1.00 PAR VALUE, $50.00 STATED VALUE OF INERGETICS, INC. (the “Corporation”), transferable on the books of the Corporation in person or by a |
|
| August 1, 2014 |
Exhibit 4.7 AMENDMENT TO THE SECURED CONVERTIBLE NOTE FROM INERGETICS, INC. TO DUE DECEMBER 31, 2013 IN THE PRINCIPAL AMOUNT OF $ AND RELATED TRANSACTION DOCUMENTS This Amendment, effective December 31, 2013 (the “Amendment”), by and between Inergetics, Inc., a corporation organized under the laws of the State of Delaware (“Inergetics”) and its wholly-owned subsidiary, Millennium Biotechnologies, |
|
| July 15, 2014 |
INERGETICS, INC. Class A Warrant To Purchase Common Stock NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY ARE EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND APPLICABLE STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSU |
|
| July 15, 2014 |
IN ACCORDANCE WITH A CERTAIN SUBORDINATION AGREEMENT BY AND AMONG THE LENDER AND THE PRIOR LENDERS, THE LENDER HAS SUBORDINATED ANY SECURITY INTEREST OR LIEN THAT LENDER MAY HAVE IN ANY PROPERTY OF THE BORROWER TO THE SECURITY INTEREST OF THE PRIOR LENDERS IN ALL ASSETS OF THE BORROWER, NOTWITHSTANDING THE RESPECTIVE DATES OF ATTACHMENT OR PERFECTION OF THE SECURITY INTEREST OF THE LENDER AND THE PRIOR LENDERS. |
|
| July 15, 2014 |
EX-10.1 4 v383835ex10-1.htm EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 14, 2014, by and between Inergetics, Inc., a Delaware corporation, with headquarters located at 550 Broad Street, Suite 1212, Newark, New Jersey 7102 (the “Company”), and 31 GROUP LLC, a New York limited liability company, with its address at 5 Hanover Squar |
|
| July 15, 2014 |
SECURED SUBORDINATED CONVERTIBLE PROMISSORY NOTE EX-4.1 2 v383835ex4-1.htm EXHIBIT 4.1 NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE RE |
|
| July 15, 2014 |
EX-10.3 6 v383835ex10-3.htm EXHIBIT 10.3 SUBSIDIARY GUARANTY 1. Identification. This Guaranty (the “Guaranty”), dated as of July 14, 2014, is entered into by Millennium Biotechnologies, Inc., a Delaware corporation (the “Guarantor”), for the benefit of 31 Group LLC (the “Lender”). 2. Recitals. 2.1 The Guarantor is a direct or indirect subsidiary of Inergetic, Inc., a Delaware corporation (“Parent” |
|
| July 15, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of report (Date of earliest event reported): July 14, 2014 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Identificat |
|
| June 3, 2014 |
EX-4.2 3 v380472ex4-2.htm EXHIBIT 4.2 ANNEX I FORM OF NOTE THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO THE CO |
|
| June 3, 2014 |
EX-10.2 5 v380472ex10-2.htm EXHIBIT 10.2 PURCHASE AGREEMENT THIS PURCHASE AGREEMENT, dated as of May 6, 2014, is entered into by and among Inergetics, Inc., (the “Company”), and Black Mountain Equities, Inc. (the “Purchaser”). WITNESSETH: WHEREAS, the Company and the Purchaser are executing and delivering this Agreement in accordance with and in reliance upon the exemption from securities registra |
|
| June 3, 2014 |
EX-10.1 4 v380472ex10-1.htm EXHIBIT 10.1 SECURITIES EXCHANGE AGREEMENT This Securities Exchange Agreement (this “Agreement”) is dated as of May 21, 2014, between Inergetics, Inc., a Delaware corporation, with offices located at 550 Broad Street, Suite 1212, Newark, NJ 07102 (the “Company”), and 31 Group, LLC, with offices located at 5 Hanover Square, New York, NY 10004 (the “Purchaser”). WHEREAS, |
|
| June 3, 2014 |
NEITHER THE ISSUANCE ANDSALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| June 3, 2014 |
8-K 1 v3804728k.htm 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2014 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-15 |
|
| May 15, 2014 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| March 31, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 INERGETICS, INC. (Exact Name of Registrant |
|
| February 14, 2014 |
NRTI / Inergetics, Inc. / FRENKEL LEONID Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| December 23, 2013 |
Other Events, Financial Statements and Exhibits 8-K 1 v3637428k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 23, 2013 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Nu |
|
| December 23, 2013 |
EX-99.1 2 v363742ex99-1.htm EXHIBIT 99.1 |
|
| November 14, 2013 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| September 5, 2013 |
NRTI / Inergetics, Inc. / SEAHORSE ENTERPRISES LLC - SCHEDULE 13G Passive Investment SC 13G 1 v354458sc13g.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Inergetics Inc. (Name of Issuer) $0.001 par value Common Stock (Title of Class of Securities) 45671Q204 (CUSIP Number) August 14, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box |
|
| August 14, 2013 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| May 15, 2013 |
LICENSE AND PROMOTION AGREEMENT by and between MARTHA STEWART LIVING OMNIMEDIA, INC. |
|
| May 15, 2013 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| May 13, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 v3448638k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2013 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) |
|
| May 13, 2013 |
EX-99.1 2 v344863ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Inergetics Announces Launch of Martha Stewart Naturals™ New Line of Whole Food Based Supplements for Women NEWARK, N.J., May 13, 2013 /PRNewswire/ - Inergetics (NRTI) announces it has entered into a partnership with Martha Stewart Living Omnimedia (MSO) to create Martha Stewart Naturals™, a line of six specially crafted supplements to support g |
|
| April 1, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 INERGETICS, INC. (Exact Name of Registrant |
|
| February 14, 2013 |
NRTI / Inergetics, Inc. / FRENKEL LEONID Passive Investment SC 13G/A 1 d135567013g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Inergetics, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 45671Q204 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des |
|
| January 4, 2013 |
8-K 1 v3313918k.htm 8-K CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 26, 2012 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commissi |
|
| December 10, 2012 |
Carol Hirth 36 West State Street PO Box 990 Trenton, NJ 08625 EX-99.1 2 v330034ex99-1.htm EXHIBIT 99.1 EXHIBIT 99.1 EDA New Jersey Economic Development Authority [Letterhead] December 5, 2012 Mr. Frank Guarino Millennium Biotechnologies Group, Inc. 205 Robin Road Suite 22 Paramus, NJ 07652 Dear Mr. Guarino: Thank you for your interest in the Technology Business Tax Certificate Transfer Program (the “Program”) and your corporation’s submission of the Selling |
|
| December 10, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 10, 2012 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employe |
|
| November 14, 2012 |
10-Q 1 v32796410q.htm FORM 10-Q FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| August 29, 2012 |
FORM 10-Q/A (Amendment No. 1) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. (Exact Name of Re |
|
| August 20, 2012 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| August 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-3338 NOTIFICATION OF LATE FILING - CUSIP NUMBER 45671Q 204 (Check One): | |Form 10-K ||Form 20-F ||Form 11-K |X|Form 10-Q | |Form 10-D | |Form N-SAR ||Form N-CSR For Period Ended: 6/30/2012 - ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( |
|
| June 11, 2012 |
8-K 1 v3157918k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 11, 2012 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number |
|
| June 1, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2012 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Ide |
|
| May 29, 2012 |
FORM 10-Q/A (Amendment No. 1) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. (Exact Name of R |
|
| May 21, 2012 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-3338 NOTIFICATION OF LATE FILING CUSIP NUMBER 45671Q204 (Check One): £ Form 10-K ¨ Form 20-F ¨ Form 11-K S Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: 3/31/12 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Repor |
|
| April 27, 2012 |
NRTI / Inergetics, Inc. / ISRAELIAN JOHN - FORM SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Inergetics, Inc. (Name of Issuer) $0.001 par value Common Stock (Title of Class of Securities) 45671Q204 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| April 16, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2011 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 INERGETICS, INC. (f/k/a MILLENNIUM BIOTECHN |
|
| April 16, 2012 |
FORM 10-Q/A (Amendment No. 1) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. (Exact Name |
|
| March 29, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-3338 NOTIFICATION OF LATE FILING - CUSIP NUMBER 45671Q204 (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: 12/31/11 - ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition |
|
| February 10, 2012 |
NRTI / Inergetics, Inc. / FRENKEL LEONID - SCHEDULE 13G AMENDMENT NO 2 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Inergetics, Inc. (Name of Issuer) $0.001 par value Common Stock (Title of Class of Securities) 45671Q204 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 31, 2012 |
NRTI / Inergetics, Inc. / CORBMAN BRIAN - FORM SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Inergetics, Inc. (Name of Issuer) $0.001 par value Common Stock (Title of Class of Securities) 60038H102 (CUSIP Number) August 8, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| November 21, 2011 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-3338 CUSIP NUMBER 60038H 10 2 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 9/30/11 - ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( ) Tran |
|
| September 16, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 16, 2011 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employ |
|
| September 8, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 8, 2011 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employe |
|
| August 19, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 19, 2011 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer |
|
| August 15, 2011 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| July 15, 2011 |
Execution Copy FUNDING AGREEMENT FUNDING AGREEMENT (the ?Agreement?), dated as of July 14, 2011, by and among Inergetics, Inc. |
|
| July 15, 2011 |
EX-10.1 15 v228806ex10-1.htm |
|
| July 15, 2011 |
EX-10.3 75 v228806ex10-3.htm |
|
| July 15, 2011 | ||
| July 15, 2011 |
EX-10.4 86 v228806ex10-4.htm |
|
| July 15, 2011 |
EX-10.5 92 v228806ex10-5.htm |
|
| July 15, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 14, 2011 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware 0-3338 22-1558317 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Id |
|
| July 15, 2011 |
CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND LIMITATIONS OF SERIES G CONVERTIBLE PREFERRED STOCK OF INERGETICS, INC. |
|
| July 15, 2011 | ||
| July 7, 2011 | ||
| July 7, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 30, 2011 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Id |
|
| June 14, 2011 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| June 8, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2010 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 INERGETICS, INC. (f/k/a MILLENNIUM BIOTECHN |
|
| May 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-3338 CUSIP NUMBER 60038H 10 2 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q oForm 10-D o Form N-SAR o Form N-CSR For Period Ended: 3/31/11 ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( ) Transit |
|
| March 29, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-3338 CUSIP NUMBER 60038H 10 2 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q oForm 10-D o Form N-SAR o Form N-CSR For Period Ended: 12/31/10 ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( ) Transi |
|
| February 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Inergetics, Inc. (Name of Issuer) $0.001 par value Common Stock (Title of Class of Securities) 60038H102 (CUSIP Number) December 31, 2010 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| November 22, 2010 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2010 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| November 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-3338 CUSIP NUMBER 60038H 10 2 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q oForm 10-D o Form N-SAR o Form N-CSR For Period Ended: 9/30/10 ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( ) Transit |
|
| October 27, 2010 |
October 27, 2010 Ms. Tabatha Akins Securities and Exchange Commission Washington, D.C. 20549 Re: Form Type CORRESP Comment Letter for Form 10-K File Number: 000-03338 Dear Ms. Akins, Please note that the Company acknowledges the following: · The Company is responsible for the adequacy and accuracy of the disclosure in the filing. · Staff comments or changes to disclosure in response to staff comme |
|
| October 26, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 INERGETICS, INC. (f/k/a MILLENNIUM BIOTEC |
|
| August 23, 2010 |
Exhibit 4.6 |
|
| August 23, 2010 |
Exhibit 4.7 |
|
| August 23, 2010 |
Exhibit 4.8 |
|
| August 23, 2010 |
Exhibit 10.11 |
|
| August 23, 2010 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| August 23, 2010 |
AMENDED AND RESTATED SECURITY AGREEMENT Exhibit 4.5 AMENDED AND RESTATED SECURITY AGREEMENT AMENDED AND RESTATED SECURITY AGREEMENT dated as of March 31, 2010 by and among Millennium Biotechnologies, Inc., a Delaware corporation (“MBI”), Inergetics, Inc. (formerly known as Millennium Biotechnologies Group, Inc.), a Delaware corporation (“Inergetics” and together with MBI the “Company”) and Ken Sadowsky, Leon Frenkel and Seahorse Enterpr |
|
| August 13, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-3338 CUSIP NUMBER Formerly 60038H 10 2 Now 45671Q 105 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 6/30/10 ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report |
|
| August 13, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Inergetics, Inc. (Name of Issuer) $0.001 par value Common Stock (Title of Class of Securities) 60038H102 (CUSIP Number) May 13, 2010 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f |
|
| May 24, 2010 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 INERGETICS, INC. |
|
| May 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-3338 NOTIFICATION OF LATE FILING CUSIP NUMBER Formerly 60038H 10 2 Now 45671Q 105 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 3/31/10 ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report |
|
| May 6, 2010 | ||
| May 6, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2010 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Iden |
|
| May 5, 2010 |
Other Events, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2010 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer Iden |
|
| May 5, 2010 |
Inergetics, Inc. Announces Ticker Symbol Change to NRTI Exhibit 99.1 Inergetics, Inc. Announces Ticker Symbol Change to NRTI PARAMUS, N.J. – May 5, 2010 – Inergetics, Inc. (OTCBB:MBTG), a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, announced today that the Company’s ticker symbol, as quoted on the OTC Bulletin Board, will change from MBTG to NRTI, effective at the open of business tomorrow, May 6, 20 |
|
| April 28, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 27, 2010 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer I |
|
| April 27, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 20, 2010 INERGETICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558317 (IRS Employer I |
|
| April 15, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2009 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 INERGETICS, INC. (f/k/a MILLENNIUM BIOT |
|
| April 15, 2010 |
EX-10.11 5 v181184ex10-11.htm |
|
| April 15, 2010 | ||
| April 15, 2010 |
EX-10.12 17 v181184ex10-12.htm |
|
| March 30, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 12/31/09 - ( ) Transition Report on Form 10-K ( ) Transition Report on Form 20-F ( ) Transition Report on Form 11-K ( ) Transition Report on Form 10-Q ( ) Transition Repor |
|
| March 18, 2010 |
Millennium Biotechnologies, Inc. Announces Corporate Name Change to Inergetics, Inc. Millennium Biotechnologies, Inc. Announces Corporate Name Change to Inergetics, Inc. PARAMUS, N.J., March 17, 2010 (GLOBE NEWSWIRE) - Millennium Biotechnologies Group Inc. (OTCBB:MBTG - - News), a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, announced today that the Company has officially changed its name to Inergetics, Inc., effective immediatel |
|
| March 18, 2010 |
SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 12, 2010 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1 |
|
| March 12, 2010 |
Beverage Industry Expert Ken Sadowsky Rejoins Millennium Biotechnologies' Board of Directors Exhibit 99.1 Beverage Industry Expert Ken Sadowsky Rejoins Millennium Biotechnologies' Board of Directors Senior Beverages Advisor for Verlinvest Rejoins Board Following Company's Capital Restructuring PARAMUS, N.J., March 8, 2010 (GLOBE NEWSWIRE) - Millennium Biotechnologies Group Inc. (OTCBB:MBTG - - News), a leader in targeted product development for the Clinical Nutrition and Sports Supplement |
|
| March 12, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 8, 2010 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-15 |
|
| March 4, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60038H102 (CUSIP Number) February 23, 2010 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 16, 2010 |
SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Solicitation Material Pursuant to Rule 14a-11(c) or rule 14a-12 Millennium Biotechnologies Group, Inc. |
|
| January 29, 2010 |
SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Solicitation Material Pursuant to Rule 14a-11(c) or rule 14a-12 Millennium Biotechnologies Group, Inc. |
|
| November 19, 2009 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2009 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| November 17, 2009 |
EX-4.3 3 v166856ex4-3.htm NUMBER SHARES MILLENNIUM BIOTECHNOLOGIES GROUP, INC. incorporated under the laws of the state of delaware SERIES E CONVERTIBLE PREFERRED STOCK THIS CERTIFIES THAT is the record holder of FULLY PAID AND NON-ASSESSABLE SHARES OF SERIES E CONVERTIBLE PREFERRED STOCK, $1.00 PAR VALUE, OF MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (the “Corporation”), transferable on the books of |
|
| November 17, 2009 |
SECOND AMENDMENT TO SECURITY AGREEMENTS AND CONVERTIBLE PROMISSORY NOTE Execution Version SECOND AMENDMENT TO SECURITY AGREEMENTS AND CONVERTIBLE PROMISSORY NOTE THIS SECOND AMENDMENT TO SECURITY AGREEMENTS AND CONVERTIBLE PROMISSORY NOTE (this “Amendment”) is effective as of the 1st day of August, 2009 (the “Effective Date”) and made by and among MILLENNIUM BIOTECHNOLOGIES, INC. |
|
| November 17, 2009 |
Confidential Page 1 SERVICE AGREEMENT This Service Agreement (the “Agreement”) made as of August 1, 2009 (the “Effective Date”) by and between Ventiv Commercial Services, LLC, a New Jersey limited liability company (“Ventiv) and Millennium Biotechnologies, Inc. |
|
| November 17, 2009 |
Unit Note No. THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE, AND ARE ISSUED IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT (i) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES |
|
| November 17, 2009 |
NUMBER SHARES MILLENNIUM BIOTECHNOLOGIES GROUP, INC. incorporated under the laws of the state of delaware SERIES F CONVERTIBLE PREFERRED STOCK THIS CERTIFIES THAT is the record holder of FULLY PAID AND NON-ASSESSABLE SHARES OF SERIES F CONVERTIBLE PREFERRED STOCK, $1.00 PAR VALUE, OF MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (the “Corporation”), transferable on the books of the Corporation in person |
|
| November 17, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 10, 2009 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware 0-3338 22-1558317 (State or Other Jurisdiction (Commission (IRS Employer of Inco |
|
| November 17, 2009 |
SUBORDINATION AGREEMENT THIS SUBORDINATION AGREEMENT (this “Agreement”) dated August , 2009, is made by Ventiv Commercial Services, LLC, a New Jersey limited liability company, having a place of business at 500 Atrium Drive, Somerset, New Jersey 08873 (“Creditor”), Millennium Biotechnologies Group, Inc. |
|
| October 13, 2009 |
SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 6, 2009 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22- |
|
| October 13, 2009 |
Exhibit 3.1 CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND LIMITATIONS OF SERIES E CONVERTIBLF PREFERRED STOCK AND SERIES F CONVERTIBLE PREFERRED STOCK OF MILLENNIUM BIOTECHNOLOGIES GROUP, INC. Acting pursuant to Sections 151(a) and (g) of the Delaware General Corporation Law, the undersigned, Mark Mirken, the duly elected and acting Chief Executive Officer of Millennium Biotechnologies Gro |
|
| September 30, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2009 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1558 |
|
| August 19, 2009 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| July 14, 2009 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Millennium Biotechnologies Group, Inc. (Name of Issuer) $0.001 par value Common Stock (Title of Class of Securities) 60038H102 (CUSIP Number) February 14, 2009 ** (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate bo |
|
| June 30, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 25, 2009 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-15 |
|
| June 22, 2009 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2009 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| May 4, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2008 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GR |
|
| November 19, 2008 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| October 16, 2008 | ||
| October 16, 2008 |
Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors Wednesday September 17, 1:05 pm ET BASKING RIDGE, N. |
|
| October 16, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2008 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact name of registrant as specified in its charter) Delaware 0-3338 22-1558317 (State or other jurisdiction of incorporati |
|
| October 16, 2008 | ||
| August 19, 2008 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| August 12, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2008 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-1 |
|
| August 12, 2008 |
Mark C. Mirken named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. Exhibit 99.1 Mark C. Mirken named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. Basking Ridge, New Jersey, August 6, 2008 Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTCBB:MBTG) today named Mark C. Mirken its new Chief Executive Officer and Chairman of its Board of Directors. Mirken has been President and Chief Oper |
|
| June 6, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 31, 2008 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-155 |
|
| June 6, 2008 |
Exhibit 99.1 Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc. Amended Master Purchase Contract Provides for the Sale of Ready to Drink Suite of Nutritional Supplements to Provider Services, Inc to be Increased Annually by $3.4M or 142% Basking Ridge, NJ June 5, 2008: Millennium Biotechnologies Inc, wholly owned subsidiary |
|
| May 20, 2008 |
FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| April 18, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No )* MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60038H102 (CUSIP Number) April 9, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| April 15, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2007 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (E |
|
| December 7, 2007 |
Exhibit 10.4 SECURITY INTEREST AGREEMENT The undersigned, MILLENNIUM BIOTECHNOLOGIES, INC. (“Millennium” or “Debtor”), a Delaware corporation with headquarters located at 665 Martinsville Road, Suite 219, Basking Ridge, NJ, for value received, hereby grants unto Harborview Master Fund LP (“Harborview” or the “Secured Party”), a limited partnership organized and existing under the laws of the Briti |
|
| December 7, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 30, 2007 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 2 |
|
| December 7, 2007 |
EX-10.3 4 v096191ex10-3.htm Exhibit 10.3 SECURITY INTEREST AGREEMENT SECURITY INTEREST AGREEMENT ("Security Interest Agreement"), dated as of November 30, 2007, by and between HARBORVIEW MASTER FUND LP (the “Secured Party”), with headquarters c/o Navigator Management Ltd., Harbour House, 2d Floor, Road Town, Tortola, BVI and MILLENNIUM BIOTECHNOLOGIES, INC., a Delaware corporation with headquarter |
|
| December 7, 2007 |
Exhibit 10.1 LOAN AGREEMENT THIS LOAN AGREEMENT, dated as of November 30, 2007, is entered into by and between MILLENNIUM BIOTECHNOLOGIES GROUP, INC., a Delaware corporation with headquarters located at 665 Martinsville Road, Suite 219, Basking Ridge, NJ 07920 (the “Company”), and HARBORVIEW MASTER FUND L.P., c/o Beacon Capital Management, Harbor House, Roadtown, Tortola, BVI (the “Buyer”). W I T |
|
| December 7, 2007 |
Exhibit 10.2 THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT OR AN OPINION OF COUNSEL REASONA |
|
| December 7, 2007 |
PERSONAL GUARANTEE OF GUARANTOR Exhibit 10.5 PERSONAL GUARANTEE OF GUARANTOR Reference is made to the 6% Secured Convertible Note, dated November 30, 2007 (the “Note”), of MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (the “Company”) to HARBORVIEW MASTER FUND LP (the “Holder”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Note. This Guarantee is for the benefit of the Holder with respec |
|
| November 19, 2007 |
AMENDMENT TO EMPLOYMENT AGREEMENT CHRISTOPHER SWON Exhibit 99.5 AMENDMENT TO EMPLOYMENT AGREEMENT CHRISTOPHER SWON THIS AMENDMENT dated November 14, 2007 (the "Amendment") among Millennium Biotechnologies Group, Inc., a Delaware corporation ("Group"), Millennium Biotechnologies, Inc. (the "Company"), and Christopher Swon (the "Executive"). WHEREAS, the Executive is currently employed by the Company, a wholly owned subsidiary of Group, under an Emp |
|
| November 19, 2007 |
SECOND AMENDMENT TO EMPLOYMENT AGREEMENT JOHN SWON Exhibit 99.3 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT JOHN SWON THIS SECOND AMENDMENT dated November 14, 2007 (the "Amendment") among Millennium Biotechnologies Group, Inc., a Delaware corporation ("Group"), Millennium Biotechnologies, Inc. (the "Company"), and John Swon (the "Executive"). WHEREAS, the Executive is currently employed by the Company, a wholly owned subsidiary of Group, under an Emp |
|
| November 19, 2007 |
SECOND AMENDMENT TO EMPLOYMENT AGREEMENT JERRY T. SWON Exhibit 99.4 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT JERRY T. SWON THIS SECOND AMENDMENT dated November 14, 2007 (the "Amendment") among Millennium Biotechnologies Group, Inc., a Delaware corporation ("Group"), Millennium Biotechnologies, Inc. (the "Company"), and Jerry T. Swon (the "Executive"). WHEREAS, the Executive is currently employed by the Company, a wholly owned subsidiary of Group, unde |
|
| November 19, 2007 |
EXCLUSIVE MASTER PURCHASE AGREEMENT Exhibit 99.1 EXCLUSIVE MASTER PURCHASE AGREEMENT This Exclusive Master Purchase Agreement ("Agreement") is entered into and is effective as of November 9, 2007 ("Effective Date") by and between MILLENNIUM BIOTECHNOLOGIES, INC. a Delaware corporation (a wholly owned subsidiary of "Millennium Biotechnologies Group, Inc.") having its principal place of business at 665 Martinsville Road, Suite 219, Ba |
|
| November 19, 2007 |
FORM 10-QSB SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended September 30, 2007 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| November 19, 2007 |
AMENDMENT TO EMPLOYMENT AGREEMENT FRANK GUARINO Exhibit 99.2 AMENDMENT TO EMPLOYMENT AGREEMENT FRANK GUARINO AMENDMENT dated November 14, 2007 (the "Amendment") among Millennium Biotechnologies Group, Inc., a Delaware corporation ("Group"), Millennium Biotechnologies, Inc. (the "Company"), and Frank Guarino (the "Executive"). WHEREAS, the Executive is currently employed by the Company, a wholly owned subsidiary of Group, under an Employment Agr |
|
| September 11, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 11, 2007 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) |
|
| September 11, 2007 |
MARK C. MIRKEN EMPLOYMENT AGREEMENT MARK C. MIRKEN EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (the “Agreement”), dated as of September 4, 2007, by and among Millennium Biotechnologies, Inc., a Delaware corporation (“Company”), Millennium Biotechnologies Group Inc. (“Group”) and Mark C. Mirken (“Executive”). WHEREAS, the Company is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional su |
|
| September 7, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 15, 2007 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22- |
|
| September 7, 2007 |
Millennium Biotechnologies Group, Inc (MBTG.OB) Announces Completion of $2,277,000 Equity Financing Millennium Biotechnologies Group, Inc (MBTG.OB) Announces Completion of $2,277,000 Equity Financing. BASKING RIDGE, N.J. September 7, 2007, Millennium Biotechnologies Group, Inc. (OTC BB:MBTG.OB) announced that it raised $2,277,000 through the private placement of its equity securities. These securities have not been registered under the Securities Act of 1933 and may not be offered or sold in the |
|
| August 20, 2007 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-QSB x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended June 30, 2007 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| May 21, 2007 |
FORM 10-QSB SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarter Ended March 31, 2007 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. |
|
| April 18, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2006 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE OF 1934 For the Transition Period From to Commission file number 0-3338 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (E |
|
| March 9, 2007 |
Termination of a Material Definitive Agreement SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 5, 2007 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22-15 |
|
| November 1, 2006 |
Millennium Biotechnologies Group Enters into Asset Purchase Agreement with Aisling Capital to exchange Nutraceutical Business for Equity in Newly Formed Company BASKING RIDGE, N. |
|
| November 1, 2006 |
ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (?Agreement?) is made and entered into as of the 25th day of October, 2006 (the ?Effective Date?), by and among RAC Nutrition Corporation, a Delaware corporation, (the ?Buyer?), and Millennium Biotechnologies Group, Inc. |
|
| November 1, 2006 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 25, 2006 MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission File Number) 22 |
|
| April 5, 2006 |
Other Events, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 5, 2006 (April 5, 2006) MILLENNIUM BIOTECHNOLOGIES GROUP, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-3338 (Commission Fi |
|
| April 5, 2006 |
Exhibit 99.1 Millennium Biotechnologies Group Enters into Letter of Intent with Aisling Capital to Sell Assets to Newly Formed Company in Exchange for Common Stock BASKING RIDGE, N.J. (BUSINESS WIRE): April 5, 2006, Millennium Biotechnologies Group, Inc. (MBTG) announced today that it has entered into a letter of intent with Aisling Capital II, LP which, if consummated, would result in the sale by |
|
| August 12, 2004 |
Unassociated Document As filed with the Securities and Exchange Commission on August 12, 2004 Registration No. |
|
| August 12, 2004 | ||
| June 8, 2004 |
EX-4.5 4 warrantb.txt THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASON |
|
| June 8, 2004 |
Exhibit 21.1 SUBSIDIARIES OF THE COMPANY Millennium Biotechnologies, Inc., a Delaware corporation. |
|
| June 8, 2004 |
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. |
|
| June 8, 2004 |
As filed with the Securities and Exchange Commission on June 8, 2004 Unassociated Document As filed with the Securities and Exchange Commission on June 8, 2004 Registration No. |
|
| June 8, 2004 |
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. |
|
| June 8, 2004 |
SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT (this "Agreement"), dated as of April 30, 2004, by and among Millennium Biotechnologies Group, Inc. |
